BIOLASE, INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Biolase, Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Biolase, Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $35.8M, a 14.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $35.8M +$4.57M +14.6% Dec 31, 2023 10-K 2024-03-21
Q4 2022 $31.2M +$3.97M +14.6% Dec 31, 2022 10-K 2024-03-21
Q4 2021 $27.3M -$24.9M -47.7% Dec 31, 2021 10-K 2023-03-28
Q4 2020 $52.2M -$1.06M -1.99% Dec 31, 2020 10-K 2022-03-17
Q4 2019 $53.2M +$6.26M +13.3% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $47M +$6.1M +14.9% Dec 31, 2018 10-K 2020-03-30
Q4 2017 $40.9M -$13.4M -24.8% Dec 31, 2017 10-K 2019-03-08
Q4 2016 $54.3M +$4.8M +9.69% Dec 31, 2016 10-K 2018-03-14
Q4 2015 $49.5M +$7.45M +17.7% Dec 31, 2015 10-K 2017-03-10
Q4 2014 $42.1M +$6.5M +18.3% Dec 31, 2014 10-K 2016-03-11
Q4 2013 $35.6M +$2.23M +6.67% Dec 31, 2013 10-K 2015-03-06
Q4 2012 $33.3M -$443K -1.31% Dec 31, 2012 10-K 2014-03-17
Q4 2011 $33.8M Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.